
| (Exact name of registrant as specified in its charter) | ||
| (State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) | ||||||||||||
| (Address of principal executive offices and Zip Code) | ||
( | ||
| (Registrant’s telephone number, including area code) | ||
| Title of each class | Trading symbol | Name of each exchange on which registered | ||||||||||||
| Item 2.02. | Results of Operations and Financial Condition. | ||||
| Item 9.01. | Financial Statements and Exhibits. | ||||
| (d) Exhibits. | |||||
| Exhibit No. | Description | ||||||||||
| 99.1 | |||||||||||
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | ||||||||||
| MICRON TECHNOLOGY, INC. | |||||||||||
| Date: | By: | /s/ Mark Murphy | |||||||||
| Name: | Mark Murphy | ||||||||||
| Title: | Executive Vice President and Chief Financial Officer | ||||||||||
| Contacts: | Farhan Ahmad | Erica Rodriguez Pompen | ||||||
| Investor Relations | Media Relations | |||||||
| [email protected] | [email protected] | |||||||
| (408) 834-1927 | (408) 834-1873 | |||||||
| Quarterly Financial Results | |||||||||||||||||||||||
| (in millions, except per share amounts) | GAAP(1) | Non-GAAP(2) | |||||||||||||||||||||
| FQ2-23 | FQ1-23 | FQ2-22 | FQ2-23 | FQ1-23 | FQ2-22 | ||||||||||||||||||
| Revenue | $ | 3,693 | $ | 4,085 | $ | 7,786 | $ | 3,693 | $ | 4,085 | $ | 7,786 | |||||||||||
| Gross margin | (1,206) | 893 | 3,676 | (1,161) | 934 | 3,724 | |||||||||||||||||
| percent of revenue | (32.7 | %) | 21.9 | % | 47.2 | % | (31.4 | %) | 22.9 | % | 47.8 | % | |||||||||||
| Operating expenses | 1,097 | 1,102 | 1,130 | 916 | 999 | 974 | |||||||||||||||||
| Operating income (loss) | (2,303) | (209) | 2,546 | (2,077) | (65) | 2,750 | |||||||||||||||||
| percent of revenue | (62.4 | %) | (5.1 | %) | 32.7 | % | (56.2 | %) | (1.6 | %) | 35.3 | % | |||||||||||
| Net income (loss) | (2,312) | (195) | 2,263 | (2,081) | (39) | 2,444 | |||||||||||||||||
| Diluted earnings (loss) per share | (2.12) | (0.18) | 2.00 | (1.91) | (0.04) | 2.14 | |||||||||||||||||
| FQ3-23 | GAAP(1) Outlook | Non-GAAP(2) Outlook | ||||||
Revenue | $3.70 billion ± $200 million | $3.70 billion ± $200 million | ||||||
Gross margin | (23.0%) ± 2.5% | (21.0%) ± 2.5% | ||||||
Operating expenses | $1.07 billion ± $15 million | $900 million ± $15 million | ||||||
Diluted earnings (loss) per share | ($1.79) ± $0.07 | ($1.58) ± $0.07 | ||||||
| 2nd Qtr. | 1st Qtr. | 2nd Qtr. | Six months ended | ||||||||||||||
| March 2, 2023 | December 1, 2022 | March 3, 2022 | March 2, 2023 | March 3, 2022 | |||||||||||||
| Revenue | $ | 3,693 | $ | 4,085 | $ | 7,786 | $ | 7,778 | $ | 15,473 | |||||||
| Cost of goods sold | 4,899 | 3,192 | 4,110 | 8,091 | 8,232 | ||||||||||||
| Gross margin | (1,206) | 893 | 3,676 | (313) | 7,241 | ||||||||||||
| Research and development | 788 | 849 | 792 | 1,637 | 1,504 | ||||||||||||
| Selling, general, and administrative | 231 | 251 | 263 | 482 | 522 | ||||||||||||
| Restructure and asset impairments | 86 | 13 | 5 | 99 | 43 | ||||||||||||
| Other operating (income) expense, net | (8) | (11) | 70 | (19) | (5) | ||||||||||||
| Operating income (loss) | (2,303) | (209) | 2,546 | (2,512) | 5,177 | ||||||||||||
| Interest income | 119 | 88 | 12 | 207 | 22 | ||||||||||||
| Interest expense | (89) | (51) | (55) | (140) | (100) | ||||||||||||
| Other non-operating income (expense), net | 2 | (4) | 6 | (2) | (69) | ||||||||||||
| (2,271) | (176) | 2,509 | (2,447) | 5,030 | |||||||||||||
| Income tax (provision) benefit | (54) | (8) | (255) | (62) | (474) | ||||||||||||
| Equity in net income (loss) of equity method investees | 13 | (11) | 9 | 2 | 13 | ||||||||||||
| Net income (loss) | $ | (2,312) | $ | (195) | $ | 2,263 | $ | (2,507) | $ | 4,569 | |||||||
| Earnings (loss) per share | |||||||||||||||||
| Basic | $ | (2.12) | $ | (0.18) | $ | 2.02 | $ | (2.30) | $ | 4.08 | |||||||
| Diluted | (2.12) | (0.18) | 2.00 | (2.30) | 4.04 | ||||||||||||
| Number of shares used in per share calculations | |||||||||||||||||
| Basic | 1,091 | 1,090 | 1,119 | 1,091 | 1,119 | ||||||||||||
| Diluted | 1,091 | 1,090 | 1,130 | 1,091 | 1,130 | ||||||||||||
| As of | March 2, 2023 | December 1, 2022 | September 1, 2022 | ||||||||
| Assets | |||||||||||
| Cash and equivalents | $ | 9,798 | $ | 9,574 | $ | 8,262 | |||||
| Short-term investments | 1,020 | 1,007 | 1,069 | ||||||||
| Receivables | 2,278 | 3,318 | 5,130 | ||||||||
| Inventories | 8,129 | 8,359 | 6,663 | ||||||||
| Other current assets | 673 | 663 | 657 | ||||||||
| Total current assets | 21,898 | 22,921 | 21,781 | ||||||||
| Long-term marketable investments | 1,212 | 1,426 | 1,647 | ||||||||
| Property, plant, and equipment | 39,085 | 39,335 | 38,549 | ||||||||
| Operating lease right-of-use assets | 673 | 693 | 678 | ||||||||
| Intangible assets | 410 | 428 | 421 | ||||||||
| Deferred tax assets | 697 | 672 | 702 | ||||||||
| Goodwill | 1,228 | 1,228 | 1,228 | ||||||||
| Other noncurrent assets | 1,317 | 1,171 | 1,277 | ||||||||
| Total assets | $ | 66,520 | $ | 67,874 | $ | 66,283 | |||||
| Liabilities and equity | |||||||||||
| Accounts payable and accrued expenses | $ | 4,310 | $ | 5,438 | $ | 6,090 | |||||
| Current debt | 237 | 171 | 103 | ||||||||
| Other current liabilities | 708 | 916 | 1,346 | ||||||||
| Total current liabilities | 5,255 | 6,525 | 7,539 | ||||||||
| Long-term debt | 12,037 | 10,094 | 6,803 | ||||||||
| Noncurrent operating lease liabilities | 610 | 625 | 610 | ||||||||
| Noncurrent unearned government incentives | 529 | 516 | 589 | ||||||||
| Other noncurrent liabilities | 832 | 808 | 835 | ||||||||
| Total liabilities | 19,263 | 18,568 | 16,376 | ||||||||
| Commitments and contingencies | |||||||||||
| Shareholders’ equity | |||||||||||
| Common stock | 123 | 123 | 123 | ||||||||
| Additional capital | 10,633 | 10,335 | 10,197 | ||||||||
| Retained earnings | 44,426 | 46,873 | 47,274 | ||||||||
| Treasury stock | (7,552) | (7,552) | (7,127) | ||||||||
| Accumulated other comprehensive income (loss) | (373) | (473) | (560) | ||||||||
| Total equity | 47,257 | 49,306 | 49,907 | ||||||||
| Total liabilities and equity | $ | 66,520 | $ | 67,874 | $ | 66,283 | |||||
| Six months ended | March 2, 2023 | March 3, 2022 | ||||||
| Cash flows from operating activities | ||||||||
| Net income (loss) | $ | (2,507) | $ | 4,569 | ||||
Adjustments to reconcile net income (loss) to net cash provided by operating activities: | ||||||||
| Depreciation expense and amortization of intangible assets | 3,863 | 3,413 | ||||||
| Provision to write-down inventories to net realizable value | 1,430 | — | ||||||
| Stock-based compensation | 303 | 247 | ||||||
| (Gain) loss on debt repurchases | — | 83 | ||||||
Change in operating assets and liabilities: | ||||||||
| Receivables | 2,910 | (44) | ||||||
| Inventories | (2,896) | (900) | ||||||
| Accounts payable and accrued expenses | (1,795) | 107 | ||||||
| Other | (22) | 91 | ||||||
| Net cash provided by operating activities | 1,286 | 7,566 | ||||||
| Cash flows from investing activities | ||||||||
| Expenditures for property, plant, and equipment | (4,654) | (5,876) | ||||||
| Purchases of available-for-sale securities | (293) | (922) | ||||||
| Proceeds from maturities of available-for-sale securities | 765 | 631 | ||||||
| Proceeds from government incentives | 64 | 66 | ||||||
| Proceeds from sales of available-for-sale securities | 8 | 172 | ||||||
| Proceeds from sale of Lehi, Utah fab | — | 893 | ||||||
| Other | (71) | (140) | ||||||
| Net cash provided by (used for) investing activities | (4,181) | (5,176) | ||||||
| Cash flows from financing activities | ||||||||
| Proceeds from issuance of debt | 5,221 | 2,000 | ||||||
| Repurchases of common stock - repurchase program | (425) | (667) | ||||||
| Payments of dividends to shareholders | (252) | (224) | ||||||
| Payments on equipment purchase contracts | (76) | (105) | ||||||
| Repayments of debt | (53) | (1,981) | ||||||
| Other | 19 | (2) | ||||||
| Net cash provided by (used for) financing activities | 4,434 | (979) | ||||||
Effect of changes in currency exchange rates on cash, cash equivalents, and restricted cash | 9 | (16) | ||||||
| Net increase (decrease) in cash, cash equivalents, and restricted cash | 1,548 | 1,395 | ||||||
| Cash, cash equivalents, and restricted cash at beginning of period | 8,339 | 7,829 | ||||||
| Cash, cash equivalents, and restricted cash at end of period | $ | 9,887 | $ | 9,224 | ||||
| 2nd Qtr. | 1st Qtr. | 2nd Qtr. | |||||||||
| March 2, 2023 | December 1, 2022 | March 3, 2022 | |||||||||
| GAAP gross margin | $ | (1,206) | $ | 893 | $ | 3,676 | |||||
| Stock-based compensation | 41 | 36 | 44 | ||||||||
| Other | 4 | 5 | 4 | ||||||||
| Non-GAAP gross margin | $ | (1,161) | $ | 934 | $ | 3,724 | |||||
| GAAP operating expenses | $ | 1,097 | $ | 1,102 | $ | 1,130 | |||||
| Stock-based compensation | (95) | (90) | (75) | ||||||||
| Restructure and asset impairments | (86) | (13) | (5) | ||||||||
| Other | — | — | (76) | ||||||||
| Non-GAAP operating expenses | $ | 916 | $ | 999 | $ | 974 | |||||
| GAAP operating income (loss) | $ | (2,303) | $ | (209) | $ | 2,546 | |||||
| Stock-based compensation | 136 | 126 | 119 | ||||||||
| Restructure and asset impairments | 86 | 13 | 5 | ||||||||
| Other | 4 | 5 | 80 | ||||||||
| Non-GAAP operating income (loss) | $ | (2,077) | $ | (65) | $ | 2,750 | |||||
GAAP net income (loss) | $ | (2,312) | $ | (195) | $ | 2,263 | |||||
| Stock-based compensation | 136 | 126 | 119 | ||||||||
| Restructure and asset impairments | 86 | 13 | 5 | ||||||||
| Amortization of debt discount and other costs | 4 | 5 | 8 | ||||||||
| Other | 4 | 5 | 80 | ||||||||
Estimated tax effects of above and other tax adjustments | 1 | 7 | (31) | ||||||||
| Non-GAAP net income (loss) | $ | (2,081) | $ | (39) | $ | 2,444 | |||||
GAAP weighted-average common shares outstanding - Diluted | 1,091 | 1,090 | 1,130 | ||||||||
Adjustment for stock-based compensation | — | — | 13 | ||||||||
Non-GAAP weighted-average common shares outstanding - Diluted | 1,091 | 1,090 | 1,143 | ||||||||
GAAP diluted earnings (loss) per share | $ | (2.12) | $ | (0.18) | $ | 2.00 | |||||
Effects of the above adjustments | 0.21 | 0.14 | 0.14 | ||||||||
Non-GAAP diluted earnings (loss) per share | $ | (1.91) | $ | (0.04) | $ | 2.14 | |||||
| 2nd Qtr. | 1st Qtr. | 2nd Qtr. | |||||||||
| March 2, 2023 | December 1, 2022 | March 3, 2022 | |||||||||
GAAP net cash provided by operating activities | $ | 343 | $ | 943 | $ | 3,628 | |||||
Expenditures for property, plant, and equipment | (2,205) | (2,449) | (2,611) | ||||||||
| Proceeds from sales of property, plant, and equipment | 17 | 23 | 27 | ||||||||
Payments on equipment purchase contracts | (29) | (47) | (27) | ||||||||
Amounts funded by partners | 62 | 2 | 11 | ||||||||
| Investments in capital expenditures, net | (2,155) | (2,471) | (2,600) | ||||||||
Adjusted free cash flow | $ | (1,812) | $ | (1,528) | $ | 1,028 | |||||
| FQ3-23 | GAAP Outlook | Adjustments | Non-GAAP Outlook | ||||||||||||||||||||
Revenue | $3.70 billion ± $200 million | — | $3.70 billion ± $200 million | ||||||||||||||||||||
Gross margin | (23.0%) ± 2.5% | 2.0% | A | (21.0%) ± 2.5% | |||||||||||||||||||
Operating expenses | $1.07 billion ± $15 million | $166 million | B | $900 million ± $15 million | |||||||||||||||||||
Diluted earnings (loss) per share(1) | ($1.79) ± $0.07 | $0.21 | A, B, C | ($1.58) ± $0.07 | |||||||||||||||||||
Non-GAAP Adjustments (in millions) | |||||||||||||||||||||||
A | Stock-based compensation – cost of goods sold | $ | 55 | ||||||||||||||||||||
A | Other – cost of goods sold | 5 | |||||||||||||||||||||
B | Stock-based compensation – research and development | 62 | |||||||||||||||||||||
B | Stock-based compensation – selling, general, and administrative | 44 | |||||||||||||||||||||
| B | Restructure and asset impairments | 60 | |||||||||||||||||||||
C | Tax effects of the above items and other tax adjustments | 5 | |||||||||||||||||||||
| $ | 231 | ||||||||||||||||||||||